Patents by Inventor Joseph R. Fischer, Jr.

Joseph R. Fischer, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combined cholesterol and bilirubin tests as risk predictors for coronary artery disease
    Patent number: 6869802
    Abstract: A new method for predicting the risk of coronary artery disease (CAD) is disclosed. The method uses a ratio made up of the levels of an individuals LDL-cholesterol (LDL-C), HDL-cholesterol (HDL-C) and serum total bilirubin (bilirubin). The ratio, using a weighted value for bilirubin, is LDL-C/(HDL-C+bilirubin).
    Type: Grant
    Filed: November 9, 2001
    Date of Patent: March 22, 2005
    Assignee: The United States of America as represented by the Secretary of the Air Force
    Inventors: Harvey A. Schwertner, Joseph R. Fischer, Jr.
  • Bilirubin tests as risk predictors for cancer mortality, rheumatoid arthritis, Gilbert's syndrome and all-cause mortality
    Patent number: 6720189
    Abstract: A new method for predicting the risk of future cancer mortality, rheumatoid arthritis and all-cause mortality is disclosed. The method uses serum bilirubin levels as indicator for such risks, lower serum bilirubin levels generally indicating increased risk and higher levels a decreased risk.
    Type: Grant
    Filed: November 9, 2001
    Date of Patent: April 13, 2004
    Assignee: The United States of America as represented by the Secretary of the Air Force
    Inventors: Harvey A. Schwertner, Joseph R. Fischer, Jr.